Authors


Kunal Naik

Latest:

Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance Perspective

This article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.


Shide Badri

Latest:

Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance Perspective

This article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.


Ugo Benson-Nwoji

Latest:

Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance Perspective

This article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.


Penelope Manasco M.D.

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Michelle Pallas

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Lisa Danzig M.D.

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Charlene Kimmel

Latest:

Risk-Based Monitoring Versus Source Data Verification

Pilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.


Sean Bennett M.D., Ph.D.

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Garrett Manasco

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Deborah Thompson MPH

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Lisa Bedell MA

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


Everett Lambeth

Latest:

Risk-Based Monitoring Versus Source Data Verification

Pilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.


Kevin Fielman Ph.D.

Latest:

Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.


ICON

Latest:

The Evolving Relationship Between Sponsors and Contract Research Organizations

If the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at ICON, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.


Betsy Fields Smith

Latest:

Human Centered Design—A Pathway to Patient Centricity

uMotif worked with IDEO to shape a patient-centric approach by focusing on human-centered design.


Bruce Hellman

Latest:

Patient Centricity: The Journey Matters

Five proactive steps industry can take to optimize a patient's clinical trial experience.


Sebastian Turek

Latest:

Alzheimer’s Clinical Trials: Obstacles and Opportunities

For sponsors who are pursuing the goal of treating Alzheimer’s disease, understanding the obstacles inherent in Alzheimer’s clinical trials can help in planning for, and overcoming, these challenges.


Jason Birri

Latest:

A Roadmap to Phase I Challenges for Cell and Gene Therapy Products

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.


Nicole Gallo

Latest:

A Roadmap to Phase I Challenges for Cell and Gene Therapy Products

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.


Chris Kelly

Latest:

A Roadmap to Phase I Challenges for Cell and Gene Therapy Products

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.


Julie Kristen Hagan

Latest:

A Roadmap to Phase I Challenges for Cell and Gene Therapy Products

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.


David Bowser

Latest:

A United Front for Better Pediatric Clinical Trials

Forming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.


Martin A. Graham, PhD

Latest:

A United Front for Better Pediatric Clinical Trials

Forming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.


Ryan Meade, JD

Latest:

3 Key Steps for Building a Successful Research Billing Compliance Process

Building an accurate and consistent billing compliance process is a complex task.


Dr. Marlis Sarkany

Latest:

Improved Understanding of Psoriasis Buoys Treatment Hopes for Patients

Advances in our understanding of the genetic, immunological, and environmental factors that contribute to the pathogenesis of psoriasis have led to the development of very effective precision therapies that alleviate patient morbidity and improve quality of life, especially for patients with moderate to severe disease.


Peter Colbourne

Latest:

A Look at Sample and Laboratory Data Management Technologies

What technologies ease clinical trial laboratory sample and data management, and what are the benefits?


Jeff Mayhew

Latest:

A Look at Sample and Laboratory Data Management Technologies

What technologies ease clinical trial laboratory sample and data management, and what are the benefits?


Stephanie Weber

Latest:

A Look at Sample and Laboratory Data Management Technologies

What technologies ease clinical trial laboratory sample and data management, and what are the benefits?



Karin Daun

Latest:

Developing a Logical Sourcing Strategy

The four essential steps to ensuring optimal clinical deliverable specifications and process controls.

© 2025 MJH Life Sciences

All rights reserved.